» Articles » PMID: 36494831

The Emerging Role of Epigenetic Regulation in the Progression of Silicosis

Overview
Publisher Biomed Central
Specialty Genetics
Date 2022 Dec 10
PMID 36494831
Authors
Affiliations
Soon will be listed here.
Abstract

Silicosis is one of the most severe occupational diseases worldwide and is characterized by silicon nodules and diffuse pulmonary fibrosis. However, specific treatments for silicosis are still lacking at present. Therefore, elucidating the pathogenesis of silicosis plays a significant guiding role for its treatment and prevention. The occurrence and development of silicosis are accompanied by many regulatory mechanisms, including epigenetic regulation. The main epigenetic regulatory mechanisms of silicosis include DNA methylation, non-coding RNA (ncRNA), and histone modifications. In recent years, the expression and regulation of genes related to silicosis have been explored at epigenetic level to reveal its pathogenesis further, and the identification of aberrant epigenetic markers provides new biomarkers for prediction and diagnosis of silicosis. Here, we summarize the studies on the role of epigenetic changes in the pathogenesis of silicosis to give some clues for finding specific therapeutic targets for silicosis.

Citing Articles

From Basic Research to Clinical Practice: Considerations for Treatment Drugs for Silicosis.

Li R, Kang H, Chen S Int J Mol Sci. 2023; 24(9).

PMID: 37176040 PMC: 10179659. DOI: 10.3390/ijms24098333.


Roles of histone acetylation sites in cardiac hypertrophy and heart failure.

Funamoto M, Imanishi M, Tsuchiya K, Ikeda Y Front Cardiovasc Med. 2023; 10:1133611.

PMID: 37008337 PMC: 10050342. DOI: 10.3389/fcvm.2023.1133611.

References
1.
Shi H, Wei J, He C . Where, When, and How: Context-Dependent Functions of RNA Methylation Writers, Readers, and Erasers. Mol Cell. 2019; 74(4):640-650. PMC: 6527355. DOI: 10.1016/j.molcel.2019.04.025. View

2.
Esteller M . Non-coding RNAs in human disease. Nat Rev Genet. 2011; 12(12):861-74. DOI: 10.1038/nrg3074. View

3.
Furtado C, Luciano M, da Silva Santos R, Furtado G, Moraes M, Pessoa C . Epidrugs: targeting epigenetic marks in cancer treatment. Epigenetics. 2019; 14(12):1164-1176. PMC: 6791710. DOI: 10.1080/15592294.2019.1640546. View

4.
Xu T, Yan W, Wu Q, Xu Q, Yuan J, Li Y . MiR-326 Inhibits Inflammation and Promotes Autophagy in Silica-Induced Pulmonary Fibrosis through Targeting TNFSF14 and PTBP1. Chem Res Toxicol. 2019; 32(11):2192-2203. DOI: 10.1021/acs.chemrestox.9b00194. View

5.
Ma J, Cui X, Rong Y, Zhou Y, Guo Y, Zhou M . Plasma LncRNA-ATB, a Potential Biomarker for Diagnosis of Patients with Coal Workers' Pneumoconiosis: A Case-Control Study. Int J Mol Sci. 2016; 17(8). PMC: 5000762. DOI: 10.3390/ijms17081367. View